Managing Director of RM Global Partners (US Office), Ted holds over 20 years of global banking, strategic investment, business development, and law experience in life science and consumer technology sectors.
Ted has significant cross border experience, especially in managing projects and facilitating investments in U.S., Israel and Korean companies. Ted has accumulated his track record by completing numerous innovative life sciences transactions, including over $2 billion in strategic transactions and over $200 million in private funding for start-ups. He has advised emerging biopharma/medtech venture companies as well as large corporations on their financial and strategic transactions including M&A, capital raising, strategic partnerships, and exit strategies including IPOs. Ted’s clients include large corporate groups such as Samsung, AmorePacific Group on their mergers and acquisition matters and strategic investments.
Ted is currently serving as managing member of an early stage biopharma fund, RMGP Biopharma Fund, investing with a biopharma incubator, FutuRx based in Israel, jointly owned and managed by the 3 global biopharma leaders i.e., JNJ, Takeda and Orbimed.
Ted received both a Bachelor of Arts in Business Administration and an MBA from Kyung Hee University (Seoul). He also earned an MBA from George Washington University and a J.D. from Temple University School of Law.
Broker-dealer services are provided through Beech Hill Securities ( http://www.beechhillsecurities.com/ ), Inc., a FINRA/SIPC member.